These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 36064607)

  • 41. Radiographic Findings of Mucopolysaccharidosis and Comparison with Bone Mineral Density: A Study from Southeastern Turkey.
    Ayaz E; Bozaci AE
    J Clin Densitom; 2022; 25(4):475-484. PubMed ID: 36100508
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differences in gene expression patterns, revealed by RNA-seq analysis, between various Sanfilippo and Morquio disease subtypes.
    Wiśniewska K; Gaffke L; Krzelowska K; Węgrzyn G; Pierzynowska K
    Gene; 2022 Feb; 812():146090. PubMed ID: 34896230
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Growth in patients with mucopolysaccharidosis type III (Sanfilippo disease).
    de Ruijter J; Broere L; Mulder MF; van der Ploeg AT; Rubio-Gozalbo ME; Wortmann SB; Visser G; Wijburg FA
    J Inherit Metab Dis; 2014 May; 37(3):447-54. PubMed ID: 24173409
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Retrospective chart review of urinary glycosaminoglycan excretion and long-term clinical outcomes of enzyme replacement therapy in patients with mucopolysaccharidoses.
    Jones SA; Marsden D; Koutsoukos T; Sniadecki J; Tylee K; Phillippo S; Kakkis E
    Mol Genet Metab; 2020 Aug; 130(4):255-261. PubMed ID: 32563631
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A retrospective audit of anesthetic techniques and complications in children with mucopolysaccharidoses.
    Frawley G; Fuenzalida D; Donath S; Yaplito-Lee J; Peters H
    Paediatr Anaesth; 2012 Aug; 22(8):737-44. PubMed ID: 22381044
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Two-dimensional NMR spectroscopy of urinary glycosaminoglycans from patients with different mucopolysaccharidoses.
    Hochuli M; Wüthrich K; Steinmann B
    NMR Biomed; 2003 Jun; 16(4):224-36. PubMed ID: 14558120
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cardiac manifestations of the mucopolysaccharidoses.
    Schieken RM; Kerber RE; Ionasescu VV; Zellweger H
    Circulation; 1975 Oct; 52(4):700-5. PubMed ID: 808361
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Enzyme replacement therapy for mucopolysaccharidoses I, II and VI: recommendations from a group of Brazilian F experts].
    Giugliani R; Federhen A; Muñoz Rojas MV; Vieira TA; Artigalás O; Pinto LL; Azevedo AC; Acosta AX; Bomfim C; Lourenço CM; Kim CA; Horovitz D; Souza DB; Norato D; Marinho D; Palhares D; Santos ES; Ribeiro E; Valadares ER; Guarany F; De Lucca GR; Pimentel H; Souza IN; Corrêa Neto J; Fraga JC; Góes JE; Cabral JM; Simeonato J; Llerena JC; Jardim LB; Giuliani Lde R; Silva LC; Santos M; Moreira MA; Kerstenetzky M; Ribeiro M; Ruas N; Barrios P; Aranda P; Honjo R; Boy R; Costa R; Souza CF; Alcântara FF; Avilla SG; Fagondes S; Martins AM
    Rev Assoc Med Bras (1992); 2010; 56(3):271-7. PubMed ID: 20676532
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Growth impairment and limited range of joint motion in children should raise suspicion of an attenuated form of mucopolysaccharidosis: expert opinion.
    Guffon N; Journeau P; Brassier A; Leger J; Chevallier B
    Eur J Pediatr; 2019 Apr; 178(4):593-603. PubMed ID: 30740618
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Galsulfase: arylsulfatase B, BM 102, recombinant human arylsulfatase B, recombinant human N-acetylgalactosamine-4-sulfatase, rhASB.
    Drugs R D; 2005; 6(5):312-5. PubMed ID: 16128602
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification and characterization of 20 novel pathogenic variants in 60 unrelated Indian patients with mucopolysaccharidoses type I and type II.
    Uttarilli A; Ranganath P; Matta D; Md Nurul Jain J; Prasad K; Babu AS; Girisha KM; Verma IC; Phadke SR; Mandal K; Puri RD; Aggarwal S; Danda S; Sankar VH; Kapoor S; Bhat M; Gowrishankar K; Hasan AQ; Nair M; Nampoothiri S; Dalal A
    Clin Genet; 2016 Dec; 90(6):496-508. PubMed ID: 27146977
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Glycosaminoglycan levels in dried blood spots of patients with mucopolysaccharidoses and mucolipidoses.
    Kubaski F; Suzuki Y; Orii K; Giugliani R; Church HJ; Mason RW; Dũng VC; Ngoc CT; Yamaguchi S; Kobayashi H; Girisha KM; Fukao T; Orii T; Tomatsu S
    Mol Genet Metab; 2017 Mar; 120(3):247-254. PubMed ID: 28065440
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The landscape of Mucopolysaccharidosis in Southern and Eastern European countries: a survey from 19 specialistic centers.
    Tylki-Szymańska A; Almássy Z; Christophidou-Anastasiadou V; Avdjieva-Tzavella D; Barisic I; Cerkauskiene R; Cuturilo G; Djiordjevic M; Gucev Z; Hlavata A; Kieć-Wilk B; Magner M; Pecin I; Plaiasu V; Samardzic M; Zafeiriou D; Zaganas I; Lampe C
    Orphanet J Rare Dis; 2022 Mar; 17(1):136. PubMed ID: 35331284
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Incidence of the mucopolysaccharidoses in Taiwan, 1984-2004.
    Lin HY; Lin SP; Chuang CK; Niu DM; Chen MR; Tsai FJ; Chao MC; Chiu PC; Lin SJ; Tsai LP; Hwu WL; Lin JL
    Am J Med Genet A; 2009 May; 149A(5):960-4. PubMed ID: 19396827
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Biomarkers of bone remodeling in children with mucopolysaccharidosis types I, II, and VI.
    Stevenson DA; Rudser K; Kunin-Batson A; Fung EB; Viskochil D; Shapiro E; Orchard PJ; Whitley CB; Polgreen LE
    J Pediatr Rehabil Med; 2014; 7(2):159-65. PubMed ID: 25096868
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mucopolysaccharidosis III: Molecular basis and treatment.
    Spahiu L; Behluli E; Peterlin B; Nefic H; Hadziselimovic R; Liehr T; Temaj G
    Pediatr Endocrinol Diabetes Metab; 2021; 27(3):201-208. PubMed ID: 34743503
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mucopolysaccharidoses - Clinical Spectrum and Frequency of Different Types.
    Cheema HA; Malik HS; Hashmi MA; Fayyaz Z; Mushtaq I; Shahzadi N
    J Coll Physicians Surg Pak; 2017 Feb; 27(2):80-83. PubMed ID: 28292383
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Spondyloepiphyseal dysplasias and bilateral legg-calvé-perthes disease: diagnostic considerations for mucopolysaccharidoses.
    Mendelsohn NJ; Wood T; Olson RA; Temme R; Hale S; Zhang H; Read L; White KK
    JIMD Rep; 2013; 11():125-32. PubMed ID: 23657977
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Combined Hurler and Sanfilippo syndrome in a sibling pair.
    Sun A; Hopwood JJ; Thompson J; Cederbaum SD
    Mol Genet Metab; 2011 Jun; 103(2):135-7. PubMed ID: 21393040
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Survival and diagnostic age of 175 Taiwanese patients with mucopolysaccharidoses (1985-2019).
    Lin HY; Lee CL; Chang CY; Chiu PC; Chien YH; Niu DM; Tsai FJ; Hwu WL; Lin SJ; Lin JL; Chao MC; Chang TM; Tsai WH; Wang TJ; Chuang CK; Lin SP
    Orphanet J Rare Dis; 2020 Nov; 15(1):314. PubMed ID: 33160388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.